Aethlon Medical (AEMD.OB) Proving New Cancer Treatment
With the surfacing of "filtration devices," cancer treatment technology has grown immensely in the past few years. Still, the industry has stopped short of providing cancer treatments that inhibits the production of exosomes, the particles that suppress the immune response in cancer patients. Aethlon Medical (OTCBB: AEMD) thinks it has a new product that can address this unmet need.Through research studies led by Dr. Douglas Taylor at the University of Louisville, Aethlon Medical (OTCBB: AEMD) has concluded that its Aethlon Hemopurifier effectively captures the exosomes in cancer patients. Exosomes are secreted by tumors, and kill off immune cells generated to…